Galli-galli disease Q82.8

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

Galli-Galli disease; Galli-Galli Disease

History
This section has been translated automatically.

Bar roof, 1982

Definition
This section has been translated automatically.

Up to now only rarely described (14 contributions known, but certainly more frequently occurring), autosomal dominant inherited genodermatosis with reticular hyperpigmentation of the flexures, which belongs to the spectrum of reticular pigment dermatoses. Probably acantholytic variant of M. Dowling-Degos. The eponym Galli-Galli is derived from the brothers F. and W. Galli with whom the disease was first described.

Etiopathogenesis
This section has been translated automatically.

A "loss of function mutation" in the KRT5 gene was detected (as in Dowling-Degos disease). It is suspected that this mutation leads to a loss of adhesion of the keratinocytes, possibly also to a disturbance of the melanosome distribution (see histology).

Manifestation
This section has been translated automatically.

First signs of skin symptoms between the 40th and 60th year of life.

Clinical features
This section has been translated automatically.

Overall rather monomorphic clinical picture with spot-like, partly also confluent, also net-like hyperpigmentations with emphasis on flexures and intertrigines. Also localized on the chin, neck or back of the neck. In addition, disseminated, lenticular, reddish-brown, scaly papules and plaques on the neck, trunk and proximal extremities have also been described. 1 case of "segmental" distribution of skin lesions has been described.

Histology
This section has been translated automatically.

Image of the adenoidal verruca seborrhoica with digitally extended retelial ridges, thinned epidermis and orthokeratosis. Pleomorphism of the basal cell series. Focal suprabasal acantholysis up to larger blister formation. Lympho-histiocytic infiltrate in the upper dermis.

Therapy
This section has been translated automatically.

Nursing measures with replenishing externals. Antimycotic local therapy in case of detection of yeast species.

Note(s)
This section has been translated automatically.

Remember! The mutation in the KRT5 gene has already been described in Dowling-Degos disease. This supports the thesis that these are different variants of the same disease. Whether other diseases from the form of reticular hyperpigmentation such as:

are separate entities, or variants of this mutation will be discovered in the future.

Literature
This section has been translated automatically.

  1. Arnold AW et al(2012) Type 1 segmental Galli-Galli disease resulting from a previously unreported keratin 5 mutation. J Invest Dermatol132:2100-2103
  2. Bardach H et al (1982) Genodermatosis in a pair of brothers: Dowling-Degos, Grover, Darier, Hailey-Hailey or Galli-Galli disease? dermatologist 33: 378-383
  3. Braun-Falco M et al (2001) Galli-Galli disease: an unrecognized entity or an acantholytic variant of Dowling-Degos disease? J Am Acad Dermatol 45: 760-763
  4. Hanneken S et al (2011) Galli-Galli disease. Clinical and histopathologicalinvestigation
    using a case series of 18 patients. Dermatologist 62:842-851

  5. Mota R et al (2010) Classical and atypical presentation of Galli-Galli disease. Dermatologist 61: 284-286
  6. Klingm├╝ller G (1986) The M. Galli-Galli - an entity? Nude Dermatol 12: 41- 45
  7. Schmieder A et al (2012) Galli-Galli disease is an acantholytic variant of Dowling-Degos disease: additional genetic evidence in a German family. J Am Acad Dermatol 66:e250-251

Disclaimer

Please ask your physician for a reliable diagnosis. This website is only meant as a reference.

Authors

Last updated on: 29.10.2020